Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-3330-2026

Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/Catalog Number: iOS software version 2.13 Software Version: iOS software version 2.13 UDI-DI: 00389152470740 Component: No

Publicado el 7 de octubre de 2026 · Inicio del retiro: 16 de julio de 2026

Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P users to use their t:slim insulin pumps in manual mode. FSL3P users are unable to access their CGM's glucose values from within the t:slim app and cannot use their pumps in automated control (closed-loop) mode, which could lead to users experiencing hypoglycemia or hyperglycemia.

Qué hacer

Voluntary: Firm initiated · Letter

Detalles del retiro

Fabricante
Tandem Diabetes Care, Inc.
Distribuidor
US Nationwide distribution.
Lote
Lot Code: UDI-DI: 00389152470641 Software Version: 2.13 (iOS only)
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/Catalog Number: iOS software version 2.13 Software Version: iOS software version 2.13 UDI-DI: 00389152470740 Component: No fue retirado del mercado?

Sí. FDA publicó el retiro Z-3330-2026 el 7 de octubre de 2026. Peligro reportado: A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P users to use their t:slim insulin pumps in manual mode. FSL3P users are unable to access their CGM's glucose values from within the t:slim app and cannot use their pumps in automated control (closed-loop) mode, which could lead to users experiencing hypoglycemia or hyperglycemia.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter

¿Vendes productos como este?

Recalert vigila todo tu catálogo contra retiros como este, automáticamente.

Recalert también vigila fechas de caducidad para que vendas el inventario antes de que se convierta en pérdida.

Revisa tu inventario (gratis)